PKM
La Piruvato Quinasa M2 (PKM2) es una isoforma de la piruvato quinasa que desempeña un papel crucial en la glucólisis, convirtiendo fosfoenolpiruvato en piruvato. PKM2 está involucrada en la regulación de la reprogramación metabólica en células cancerosas, lo que la convierte en un objetivo potencial para la terapia contra el cáncer. Los inhibidores de PKM2 pueden alterar las vías metabólicas, reducir el crecimiento tumoral e inducir la muerte celular en las células cancerosas. En CymitQuimica, ofrecemos inhibidores de PKM2 para apoyar su investigación en metabolismo del cáncer, oncología y desarrollo terapéutico.
Se han encontrado 15 productos de "PKM"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
PKR-IN-2
CAS:<p>PKR-IN-2 is a activator of pyruvate kinase (PKR).</p>Fórmula:C24H28N4O4SPureza:99.14%Forma y color:SolidPeso molecular:468.57PKCζ/ι pseudosubstrate inhibitor
CAS:<p>PKCζ/ι pseudosubstrate inhibitor demonstrates comprehensive inhibitory activity across the protein kinase C (PKC) family and is associated with the induction of</p>Fórmula:C76H128N30O16Forma y color:SolidPeso molecular:1718.02Dimethylaminomicheliolide HCl
CAS:<p>Dimethylaminomicheliolide HCl has potential anti-inflammatory and anti-tumor activity and inhibits the proliferation of glioblastoma cells by targeting pyruvate</p>Fórmula:C17H28ClNO3Pureza:99.55%Forma y color:SoildPeso molecular:329.86PKM2-IN-10
<p>PKM2-IN-10 is a PKM2 inhibitor. It effectively suppresses the proliferation of A549 and HCC1833 cell lines with IC50 values of 3.36 μM and 9.20 μM, respectively. PKM2-IN-10 demonstrates antitumor activity in human non-small cell lung cancer (NSCLC) and mouse lung adenocarcinoma models. It is applicable for research in lung cancer.</p>Fórmula:C21H15F4N5Forma y color:SolidPeso molecular:413.12636PKM2 inhibitor G
CAS:<p>PKM2 inhibitor G is a inhibitor of pyruvate kinase.</p>Fórmula:C16H15NO3SPureza:99.89%Forma y color:SoildPeso molecular:301.36Mitapivat sulfate hydrate
CAS:<p>Mitapivat sulfate hydrate (AG 348 sulfate hydrate) is a pyruvate kinase (PK) allosteric activator, used to study pyruvate kinase deficiency.</p>Fórmula:C24H26N4O3S1H2SO43H2OPureza:99.22%Forma y color:SolidPeso molecular:526.6DASA-58
CAS:<p>DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.</p>Fórmula:C19H23N3O6S2Pureza:96.96% - 99.28%Forma y color:SolidPeso molecular:453.53Mitapivat
CAS:<p>Mitapivat (PKR-IN-1), also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.</p>Fórmula:C24H26N4O3SPureza:99.47% - 99.83%Forma y color:SolidPeso molecular:450.55PKM2-IN-1
CAS:<p>PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.</p>Fórmula:C18H19NO2S2Pureza:99.49% - 99.68%Forma y color:SolidPeso molecular:345.48TEPP-46
CAS:<p>TEPP-46 (ML265) is an activator of pyruvate kinase M2 (PKM2), selective for PKM1, PKL and PKR. TEPP-46 has antitumor activity. Cost-effective and quality-assured.</p>Fórmula:C17H16N4O2S2Pureza:98.21% - 98.77%Forma y color:SolidPeso molecular:372.46PKM2 activator 5
CAS:<p>PKM2 activator 5 is a novel and potent PKM2 activator (AC50: 0.316 µM) with potential anticancer activity for the study of cancer metabolism-related diseases.</p>Fórmula:C18H19FN2O6S2Pureza:98%Forma y color:SolidPeso molecular:442.48PKM2 activator 2
CAS:<p>PKM2 activator 2 is a pyruvate kinase M2 (PKM2) activator with an AC 50 value of 66 nM.PKM2 activator 2 has anti-tumor proliferative properties and attenuates</p>Fórmula:C20H18F2N2O4S2Pureza:99.92%Forma y color:SolidPeso molecular:452.49PKM2-IN-9
CAS:<p>PKM2-IN-9 (compound C1) is a potent inhibitor of PKM2, demonstrating a 75% inhibition rate at 50 μM. It plays a significant role in cancer research.</p>Fórmula:C24H22N4O2Forma y color:SolidPeso molecular:398.457Mitapivat hydrochloride
CAS:<p>Mitapivat (AG-348) hydrochloride is an orally active and selective allosteric activator of pyruvate kinase R (PK-R). It enhances the PK-R-catalyzed conversion of phosphoenolpyruvate to pyruvate, thereby promoting the glycolysis pathway, increasing ATP production in red blood cells, and decreasing 2,3-diphosphoglycerate (2,3-DPG) levels. Mitapivat hydrochloride is being investigated for potential use in the study of pyruvate kinase deficiency and other anemia-related disorders.</p>Fórmula:C24H27ClN4O3SForma y color:SolidPeso molecular:487.014PKR Inhibitor, negative control
CAS:<p>The PKR Inhibitor, negative control, is an inactive structural analog of RNA-dependent protein kinase (PKR) inhibitors, serving as a negative control. Additionally, it can inhibit LK-induced neuronal death, demonstrating significant neuroprotective properties.</p>Fórmula:C15H8Cl3NO2Peso molecular:340.59
